Brief: Cytodyn Announces Agreement with American Regent for Supply of Leronlimab for Treatment of COVID-19 in the U.S.
06/07/2020 11:21
July 6 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN ANNOUNCES EXECUTION OF EXCLUSIVE AGREEMENT WITH
AMERICAN
REGENT FOR DISTRIBUTION AND SUPPLY OF LERONLIMAB FOR TREATMENT
OF COVID-19 IN UNITED STATES
* CYTODYN - TO SUPPLY LERONLIMAB FOR TREATMENT OF COVID-19
FOR
DISTRIBUTION BY AMERICAN REGENT & GET QTRLY PAYMENTS BASED ON
PROFIT-SHARING ARRANGEMENT
Source text for Eikon: ID:nGNX1pFd7Z
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer